Bio-Techne (TECH) Return on Invested Capital (2016 - 2024)

Bio-Techne's Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.4% for Q2 2024.

• On a quarterly basis, Return on Invested Capital rose 27.0% year-over-year to 0.4% in Q2 2024; TTM through Jun 2024 was 0.4%, a 27.0% increase from a year earlier, with the FY2023 full-year figure at 0.31%, down 1.0% from the prior year.
• Return on Invested Capital rose to 0.4% in Q2 2024 per TECH's latest filing, from 0.28% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.4% in Q2 2024 and bottomed at 0.03% in Q1 2020.
• The 5-year median for Return on Invested Capital is 0.08% (2022), against an average of 0.11%.
• Across the five-year window, Return on Invested Capital decreased 2 bps in 2023 and gained 27 bps in 2024, its largest moves.
• Year by year, Return on Invested Capital stood at 0.04% in 2020, then surged by 106 bps to 0.09% in 2021, then dropped by 15 bps to 0.07% in 2022, then jumped by 205 bps to 0.23% in 2023, then jumped by 73 bps to 0.4% in 2024.
• Per Business Quant, the three latest TECH Return on Invested Capital figures stand at 0.4% (Q2 2024), 0.28% (Q1 2024), and 0.23% (Q4 2023).